Screener
ImmunityBio, Inc. IBRX Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 11) | ||
| Stockholders’ deficit: | ||
| Common Stock, $0.0001 par value; 1,650,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 1,047,341,146 and 1,011,800,008 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; excluding treasury stock, 163,800 shares outstanding as of March 31, 2026 and December 31, 2025 | $104 | $101 |
| Additional paid-in capital | 3,461,865 | 3,197,120 |
| Accumulated deficit | (4,359,428) | (3,726,646) |
| Accumulated other comprehensive income | 27,453 | 28,956 |
| Total ImmunityBio stockholders’ deficit | (870,006) | (500,469) |
| Noncontrolling interests | 880 | 895 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s common stock par value per share?
- ImmunityBio, Inc. (IBRX) reported common stock par value per share of $0.00 in Q1 2026.
- How has ImmunityBio, Inc.'s common stock par value per share changed year-over-year?
- ImmunityBio, Inc.'s common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for ImmunityBio, Inc.'s common stock par value per share?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about ImmunityBio, Inc.'s common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude